•
Wall ME, Wani MC: Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res. 1995 Feb 15;55(4):753-60. Pubmed•
Fuchs DA, Johnson RK: Cytologic evidence that taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poison. Cancer Treat Rep. 1978 Aug;62(8):1219-22. Pubmed•
Saville MW, Lietzau J, Pluda JM, Feuerstein I, Odom J, Wilson WH, Humphrey RW, Feigal E, Steinberg SM, Broder S, et al.: Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet. 1995 Jul 1;346(8966):26-8. Pubmed•
Gaitanis A, Staal S: Liposomal doxorubicin and nab-paclitaxel: nanoparticle cancer chemotherapy in current clinical use. Methods Mol Biol. 2010;624:385-92. Pubmed•
Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT: Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc. 1971 May 5;93(9):2325-7. Pubmed•
ABI 007. Drugs R D. 2004;5(3):155-9. Pubmed• Letourneau, P.C., et al.: J. Cell Biol., 98, 1355 (1984)
• Markman, M., et al.: Expert. Opin. Pharmacother., 3, 755 (1984)
• Stone, G.W., et al.:
• Danesi, R., et al.: Mol. Pharmacol., 47, 1106 (1984)
• Manfredi, J.J., et al.: Pharmacol. Ther., 25, 83 (1984)
• Kingston, D.G.I. et al., J. Nat. Prod., 1982, 45, 466-470, (2',7-di-Ac)
• Horwitz, S.B. et al., Ann. N.Y. Acad. Sci., 1986, 466, 733, (rev, pharmacol)
• Kingston, D.G.I., Pharmacol. Ther., 1991, 52, 1, (rev, pharmacol)
• Joel, S.P., Chem. Ind. (London), 1994, 172, (rev)
• Kingston, D.G.I. et al., J. Nat. Prod., 1990, 53, 1; 802, (bibl, rev)
• Williams, H.J. et al., Tetrahedron, 1993, 49, 6545, (pmr, conformn)
• Suffness, M. et al., Alkaloids (N.Y.), 1985, 25, 10, (rev, pharmacol)
• Slichenmyer, W.J. et al., Anti-Cancer Drugs, 1991, 2, 519, (rev)
• Fleming, P.E. et al., J.A.C.S., 1993, 115, 805, (biosynth)
• Young, D.H. et al., Experientia, 1992, 48, 882, (antifungal activity)
• Horwitz, S.B., Trends Pharmacol. Sci., 1992, 13, 134, (rev)
• Wall, M.E., Chron. Drug Discovery, 1993, 3, 327, (rev)
• Hoke, S.H. et al., J. Nat. Prod., 1994, 57, 277, (ms)
• Wani, M.S. et al., J.A.C.S., 1971, 93, 2325, (isol, nmr, ms, ir, uv)
• Falzone, C.J. et al., Tet. Lett., 1992, 33, 1169, (pmr, cmr)
• Ojima, I. et al., Tetrahedron, 1992, 48, 6985, (synth)
• Wheeler, N.C. et al., J. Nat. Prod., 1992, 55, 432, (occur)
• Hilton, B.D. et al., J. Nat. Prod., 1992, 55, 1157, (pmr)
• Stierle, A. et al., Science (Washington, D.C.), 1993, 260, 214, (isol, ms)
• Rose, W.C., Anti-Cancer Drugs, 1992, 3, 311, (rev)
• Winkler, J.D. et al., Tetrahedron, 1992, 48, 6953, (rev)
• Nicolaou, K.C. et al., Angew. Chem., Int. Ed., 1994, 33, 15, (rev)
• Huang, C.H.O. et al., J. Nat. Prod., 1986, 49, 665, (isol, deriv)
• Blechert, S. et al., Alkaloids (N.Y.), 1990, 39, 195, (rev, pharmacol)
• Potier, P., Chem. Soc. Rev., 1992, 21, 113, (rev)
• Chmurny, G.N. et al., J. Nat. Prod., 1992, 55, 414, (pmr, cmr)
• Zhang, H. et al., Yunnan Zhiwu Yanjiu, 1993, 15, 424; CA, 121, 78282e
• Sonnichsen, D.S. et al., Clin. Pharmacokinet., 1994, 27, 256, (rev, pharmacokinet)
• Hongjie, Z. et al., Heterocycles, 1994, 38, 975
• Gimon, M.E. et al., J. Nat. Prod., 1994, 57, 1404, (ms)
• Nicolaou, K.C. et al., Nature (London), 1994, 367, 630, (synth)
• Nicolaou, K.C. et al., J.A.C.S., 1995, 117, 624; 634; 645; 653, (synth)
• Taxol: Science and Applications, Ed., Suffness, M, CRC Press, Boca Raton, USA, 1995, (book)
• Shiina, I. et al., Chem. Lett., 1998, 3-4, (synth)
• Mukaiyama, T. et al., Chem. Eur. J., 1999, 5, 121-161, (Taxol, synth, rev)
• Martindale, The Extra Pharmacopoeia, 32nd edn., Pharmaceutical Press, 1999, 556
• Kerns, E.H. et al., J. Nat. Prod., 1994, 57, 1391, (ms)
• Fleming, P.E. et al., Pure Appl. Chem., 1994, 66, 2045, (biosynth)
• Kingston, D.G.I. et al., Tet. Lett., 1994, 35, 4483, (synth)
• Nogales, E. et al., Nature (London), 1995, 375, 424
• Danishefsky, S.J. et al., J.A.C.S., 1996, 118, 2843, (synth)
• Heinstein, P. et al., J.C.S. Perkin 1, 1996, 845, (ms)
• Gao, Q. et al., Acta Cryst. C, 1995, 51, 295, (cryst struct)
• Rowinsky, E.K. et al., N. Engl. J. Med., 1995, 332, 1004, (use, tox, rev)
• Wender, P.A. et al., J.A.C.S., 1997, 119, 2757, (synth)
• Gennari, C. et al., J.O.C., 1997, 62, 4746-4755, (synth)
• Kusama, H. et al., J.A.C.S., 2000, 122, 3811-3820, (synth)
• Huizing, M.T. et al., J. Chromatogr., B: Biomed. Appl., 1995, 664, 373, (hplc)
• Baloglu, E. et al., J. Nat. Prod., 1999, 62, 1068-1071, (synth)
• Vyas, D.M. et al., Prog. Med. Chem., 1995, 32, 289, (rev)
• Nicolaou, K.C. et al., Classics in Total Synthesis, Targets, Strategies, Methods, VCH, 1996, 655, (bibl, synth)
• Walker, K. et al., Phytochemistry, 2001, 58, 1-7, (biosynth, rev)
• The Chemistry and Pharmacology of Taxol(R) and its Derivatives, (Ed. Farina, V.), Elsevier, 1995, (book)
• Gao, Q. et al., Tetrahedron, 1996, 52, 2291, (cryst struct)
• Eisenhauer, E.A. et al., Drugs, 1998, 55, 5-30, (pharmacol, rev)
• Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, TAH775
• Holton, R.A. et al., J.A.C.S., 1994, 116, 1597; 1599, (synth)
• Fleming, P.E. et al., J.A.C.S., 1994, 116, 4137, (biosynth)
• Georg, G.I. et al., ACS Symp. Ser., 1995, 583, (book)
• Grothaus, P.G. et al., J. Nat. Prod., 1995, 58, 1003, (immunoassay)
• Rao, K.V., J. Het. Chem., 1997, 34, 675-680, (synth)
• Hezari, M. et al., Planta Med., 1997, 63, 291-295, (biosynth, rev)
• Ranson, M. et al., Expert Opin. Invest. Drugs, 1999, 8, 837-848
• Das, B. et al., Indian J. Chem., Sect. B, 1999, 38, 1018-1024, (rev)
有毒 (T)